Testing of Drugs Erlotinib and Docetaxel in Lung Cancer Patients Classified Regarding Their Outlook Using VeriStrat®.

Clinical trial NCT01652469 · COMPLETED

Trial details

NCT number: NCT01652469
Sponsor: ETOP IBCSG Partners Foundation
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung

Start date: 2012-08-01
Primary completion: 2015-12-01
Enrollment: 81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.